Postmenopausal women with a history of hormone therapy use have slower biological aging compared to those who never used the ...

Adjuvant cancer treatments such as chemotherapy and radiation are given after a primary cancer treatment to help prevent ...

Expert Rev Pharmacoeconomics Outcomes Res. 2012;12(3):319-333. The most recent biologic therapy to receive marketing approval, tocilizumab, was evaluated in a 24-week, randomized, placebo ...

Biological age vs chronological age was younger among postmenopausal female individuals who received hormone replacement therapy.

Biologic therapies now approved for use in inflammatory joint diseases are TNF inhibitors, T-cell modulators and B-cell depleters. They have all been shown to have clinical efficacy and are able ...

Becton, Dickinson and Company BDX, popularly known as BD, has announced the commercial release of the BD Neopak XtraFlow ...

Stay informed with critical information, news and insights throughout the Boulder Valley and Northern Colorado. AGC Biologics ...

The Phase III trial compared the efficacy of Fasenra with the standard treatment of GSK’s Nucala in patients with ...

Sanofi has added another dimension to the use of artificial intelligence (AI) to seek out new drugs, partnering with BioMap on a project to find biologic therapies in a deal that could be worth up ...

In the ever-evolving field of Alzheimer's disease research, the development of disease-modifying therapies has sparked both excitement and debate. While these therapies represent a promising shift in ...

BD announced today that it launched its Neopak XtraFlow glass prefillable syringe and expanded the capacity for the platform.